Alternative ways to develop diagnostic tools for use in resource-poor settings can, and do, exist, argue Martine Usdin, Martine Guillerm and Pierre Chirac of Doctors without Borders.
This is a preview of subscription content, log in via an institution to check access.
References
Chappuis, F., Loutan, L., Simarro, P., Lejon, V. & Buscher, P. Clin. Microbiol. Rev. 18, 133–146 (2005).
Carter, R. & Mendis, K. N. Clin. Microbiol. Rev. 15, 564–594 (2002).
Luxemburger, C. et al. Trans. R. Soc. Trop. Med. Hyg. 92, 45–49 (1998).
O'Dempsey, T. J. et al. Trans. R. Soc. Trop. Med. Hyg. 87, 662–665 (1993).
Project Selection, Decision Analysis and Profitability in the Pharmaceutical Industry http://www.wma.net/e/publications/pdf/2001/senn.pdf
Piper, R. et al. Am. J. Trop. Med. Hyg. 60, 109–118 (1999).
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-95-001.html
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Usdin, M., Guillerm, M. & Chirac, P. Neglected tests for neglected patients. Nature 441, 283–284 (2006). https://doi.org/10.1038/441283a
Published:
Issue Date:
DOI: https://doi.org/10.1038/441283a
- Springer Nature Limited